School of Clinical Medicine, The University of Queensland, Northside Clinical Unit, The Prince Charles Hospital, 627 Rode Road, Queensland, 4032, Chermside, Australia.
Department of Cardiology, The Prince Charles Hospital, Chermside, Queensland, Australia.
BMC Health Serv Res. 2021 Aug 28;21(1):883. doi: 10.1186/s12913-021-06874-7.
Little is known about the utilisation and safety of catheter ablation of atrial fibrillation (AF) among public and private sector hospitals.
To examine the uptake of AF ablations and compare procedural safety between the sectors.
Hospitalisation data from all public and private hospitals in four large Australian states (NSW, QLD, VIC and WA) were used to identify patients undergoing AF ablation from 2012 to 17. The primary endpoint was any procedure-related complications up to 30-days post-discharge. Logistic regression was used to evaluate the association between treatment at a public hospital and risk of complications adjusting for covariates.
Private hospitals performed most of the 21,654 AF ablations identified (n = 16,992, 78.5 %), on patients who were older (63.5 vs. 59.9y) but had lower rates of heart failure (7.9 % vs. 10.4 %), diabetes (10.2 % vs. 14.1 %), and chronic kidney diseases (2.4 % vs. 5.2 %) (all p < 0.001) than those treated in public hospitals. When compared with private hospitals, public hospitals had a higher crude rate of complications (7.25 % vs. 4.70 %, p < 0.001). This difference remained significant after adjustment (OR 1.74 [95 % CI 1.54-2.04]) and it occurred with both in-hospital (OR 1.83 [1.57-2.14]) and post-discharge (OR 1.39 [1.06-1.83]) complications, with certain complications including acute kidney injury (OR 5.31 [3.02-9.36]), cardiac surgery (OR 5.18 [2.19-12.27]), and pericardial effusion (OR 2.18 [1.50-3.16]).
Private hospitals performed most of AF ablations in Australia with a lower rate of complications when compared with public hospitals. Further investigations are needed to identify the precise mechanisms of this observed difference.
关于公共和私营部门医院使用导管消融治疗房颤(AF)的情况和安全性知之甚少。
检查 AF 消融的应用情况,并比较两个部门的程序安全性。
使用来自澳大利亚四个大州(新南威尔士州、昆士兰州、维多利亚州和西澳大利亚州)所有公立和私立医院的住院数据,确定 2012 年至 2017 年期间接受 AF 消融的患者。主要终点是出院后 30 天内任何与手术相关的并发症。使用逻辑回归评估在公立医院接受治疗与并发症风险之间的关联,调整协变量。
私立医院完成了 21654 例 AF 消融术中的大部分(n=16992,78.5%),患者年龄更大(63.5 岁比 59.9 岁),但心力衰竭(7.9%比 10.4%)、糖尿病(10.2%比 14.1%)和慢性肾脏病(2.4%比 5.2%)的发病率较低(均 P<0.001)。与私立医院相比,公立医院的并发症发生率更高(7.25%比 4.70%,P<0.001)。在调整后,这一差异仍然显著(OR 1.74 [95%CI 1.54-2.04]),并且在住院期间(OR 1.83 [1.57-2.14])和出院后(OR 1.39 [1.06-1.83])均存在差异,某些并发症包括急性肾损伤(OR 5.31 [3.02-9.36])、心脏手术(OR 5.18 [2.19-12.27])和心包积液(OR 2.18 [1.50-3.16])。
私立医院在澳大利亚进行了大部分 AF 消融术,其并发症发生率低于公立医院。需要进一步调查以确定观察到的这种差异的确切机制。